Physician

Michael Libby Mulhern, M.D., PH.D.

According to 2025 Medicare claims, Michael Mulhern, M.D., PH.D. (NPI: 1588975130) practices ophthalmology in the Lawrence, KS market, with the plurality of this provider's patient population coming from Douglas, KS. This provider's primary affiliated billing organization is LAWRENCE EYE CARE ASSOCIATES, P.A. (NPI: 1588619779; TIN: 480842315) and primary practice location at 66044-1838.

Mulhern's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,187 traditional Medicare patients, billed 6,822 HCPCS/CPT codes, and received $424,926 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,627 prescription claims across 283 beneficiaries totaling $157,746 in drug costs, led by Restasis (Cyclosporine). DME data shows 25 claims. Open Payments data shows 16 records totaling $328. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $117,804 to $424,926. Similarly, Part D prescription costs have risen steadily, from $49,479 to $157,746. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	943	1,760	$117,804
2016	1,174	2,331	$157,566
2017	1,411	2,918	$180,144
2018	1,237	2,862	$198,851
2019	1,136	2,659	$179,217
2020	1,067	2,462	$189,901
2021	1,212	2,755	$194,117
2022	1,208	2,822	$179,272
2023	1,185	4,410	$292,910
2024	1,187	6,822	$424,926

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	150	625	$49,479
2016	227	994	$85,274
2017	275	1,404	$123,654
2018	285	1,549	$143,543
2019	240	1,406	$116,869
2020	227	1,301	$105,635
2021	257	1,446	$116,860
2022	271	1,516	$141,779
2023	255	1,433	$130,628
2024	283	1,627	$157,746

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	30	30	$1,900
2017	46	46	$3,003
2018	33	33	$1,894
2019	30	30	$1,818
2020	12	13	$1,126
2021	14	14	$738
2022	25	25	$1,715
2023	24	24	$2,030
2024	25	25	$1,857

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	631	710	$76
92014	Established patient complete exam of visual system	354	359	$75
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	321	456	$57
92134	Imaging of retina	161	228	$25
92133	Imaging of optic nerve	277	279	$21

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	61	2,430	$48,894
Xiidra	Lifitegrast	29	1,110	$24,936
Lumigan	Bimatoprost	55	1,644	$15,514
Cyclosporine	Cyclosporine	14	600	$6,478
Combigan	Brimonidine Tartrate/Timolol	18	576	$4,761

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2303	Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d cylinder, per lens	N	13	13	$1,320
V2020	Frames, purchases	N	12	12	$537

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$328	Alcon Vision LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Libby Mulhern, M.D., PH.D.?

Tedicare shows public-source Medicare data for Michael Libby Mulhern, M.D., PH.D. (NPI 1588975130), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Libby Mulhern, M.D., PH.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Libby Mulhern, M.D., PH.D.?

Michael Libby Mulhern, M.D., PH.D. is linked to LAWRENCE EYE CARE ASSOCIATES, P.A. (billing NPI 1588619779) in the available physician profile data.

Does Michael Libby Mulhern, M.D., PH.D. have Open Payments data?

Michael Libby Mulhern, M.D., PH.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.